Stefan Gross
9Patents
3h-index
31Co-inventors
49Inventor score
Filing activity: Aug 18, 2009 → Apr 26, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8883438B2 | Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1 | Chemistry; Metallurgy | 16 | Active |
| US10610125B2 | Methods and compositions for cell-proliferation-related disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US9434979B2 | Methods and compositions for cell-proliferation-related disorders | Chemistry; Metallurgy | 6 | Active |
| US9982309B2 | Method for treating cell proliferation related disorders | Chemistry; Metallurgy | 2 | Active |
| US8575145B2 | Triazolopyridine compounds as PIM kinase inhibitors | Human Necessities | 2 | Active |
| US9370567B2 | Combination of checkpoint kinase 1 inhibitors and WEE 1 kinase inhibitors | Human Necessities | 1 | Active |
| US10711314B2 | Methods for diagnosing IDH-mutant cell proliferation disorders | Chemistry; Metallurgy | 0 | Active |
| US8987251B2 | Triazolopyridine compounds as PIM kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10434094B2 | Combination of checkpoint kinase 1 inhibitors and wee 1 kinase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.